Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH
Madrigal Pharmaceuticals |
Monday
Chair: Michael Roden (GER) 12:00 – 12:05 Introduction Michael Roden (GER) 12:05 – 12:20 NASH: a growing unmet therapeutic need Jörn Schattenberg (GER) 12:20 –